EZH2 and neoplasm: Impaired histone methyltransferase, enhancer of zeste homolog 2 (EZH2), can be recruited to solute carrier family 16 member 9 (SLC16A9), a carnitine transporter, coordinated by the direct interaction of PKM2, thus epigenetically influencing tumor progression (Zhang Y. et al., 2024).